Bicycle Therapeutics plc (BCYC) Free cash flow 2017–2025
Bicycle Therapeutics plc (BCYC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$252.0MFY2025 · since FY2017: -$2.5M → -$252.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$252.0M | -51.9% |
| FY2024 | -$166.0M | -161.1% |
| FY2023 | -$63.6M | +39.5% |
| FY2022 | -$105.1M | -524.7% |
| FY2021 | -$16.8M | +11.4% |
| FY2020 | -$19.0M | +37.1% |
| FY2019 | -$30.2M | -10.7% |
| FY2018 | -$27.3M | -978.5% |
| FY2017 | -$2.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCYC financial trends
BCYC RevenueBCYC Net incomeBCYC Net marginBCYC Gross profitBCYC Gross marginBCYC Operating incomeBCYC Operating marginBCYC Operating cash flowBCYC Capital expendituresBCYC Return on equityBCYC Stock buybacksBCYC Dividends paidBCYC Total assetsBCYC Total liabilitiesBCYC Shareholders’ equityBCYC overview →